niacinamide and Precancerous Conditions studies

niacinamide and Precancerous Conditions

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Precancerous Conditions: Pathological conditions that tend eventually to become malignant.

Research Excerpts

Excerpt	Relevance	Reference
"Sorafenib is a newly developed multitargeted protein kinase inhibitor reported to induce a variety of adverse cutaneous effects, rarely including actinic keratoses, keratocanthomas, and squamous cell carcinomas (SCCs)."	2.47	Sorafenib-induced premalignant and malignant skin lesions. ( Cohen, PR; Stewart, DJ; Williams, VL, 2011)

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (33.33)	24.3611
2020's	1 (16.67)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

3 (50.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

2 (33.33)

24.3611

2020's

1 (16.67)

2.80

Authors

Authors	Studies
Wang, N	3
Pan, D	3
Wang, X	6
Su, M	3
Yan, Q	3
Sun, G	3
Wang, S	3
Yoshiji, H	1
Noguchi, R	1
Namisaki, T	1
Moriya, K	1
Kitade, M	1
Aihara, Y	1
Douhara, A	1
Kawaratani, H	1
Nishimura, N	1
Fukui, H	1
Williams, VL	1
Cohen, PR	1
Stewart, DJ	1
Hadnagy, C	1
Korting, GW	1
Kröger, I	1
Werchau, H	1
Kröger, H	1

Studies

Wang, N

Pan, D

Wang, X

Su, M

Yan, Q

Sun, G

Wang, S

Yoshiji, H

Noguchi, R

Namisaki, T

Moriya, K

Kitade, M

Aihara, Y

Douhara, A

Kawaratani, H

Nishimura, N

Fukui, H

Williams, VL

Cohen, PR

Stewart, DJ

Hadnagy, C

Korting, GW

Kröger, I

Werchau, H

Kröger, H

Reviews

1 review available for niacinamide and Precancerous Conditions

Article	Year
Sorafenib-induced premalignant and malignant skin lesions. International journal of dermatology, 2011, Volume: 50, Issue:4 Topics: Antineoplastic Agents; Benzenesulfonates; Humans; Niacinamide; Phenylurea Compounds; Precancerous Co	2011

Article

Year

Sorafenib-induced premalignant and malignant skin lesions.

International journal of dermatology, 2011, Volume: 50, Issue:4

Topics: Antineoplastic Agents; Benzenesulfonates; Humans; Niacinamide; Phenylurea Compounds; Precancerous Co

2011

Other Studies

5 other studies available for niacinamide and Precancerous Conditions

Article	Year
NAPRT, but Not NAMPT, Provides Additional Support for NAD Synthesis in Esophageal Precancerous Lesions. Nutrients, 2022, Nov-20, Volume: 14, Issue:22 Topics: Case-Control Studies; Esophageal Neoplasms; Humans; NAD; Niacin; Niacinamide; Nicotinamide Phosphori	2022
NAPRT, but Not NAMPT, Provides Additional Support for NAD Synthesis in Esophageal Precancerous Lesions. Nutrients, 2022, Nov-20, Volume: 14, Issue:22 Topics: Case-Control Studies; Esophageal Neoplasms; Humans; NAD; Niacin; Niacinamide; Nicotinamide Phosphori	2022
NAPRT, but Not NAMPT, Provides Additional Support for NAD Synthesis in Esophageal Precancerous Lesions. Nutrients, 2022, Nov-20, Volume: 14, Issue:22 Topics: Case-Control Studies; Esophageal Neoplasms; Humans; NAD; Niacin; Niacinamide; Nicotinamide Phosphori	2022
NAPRT, but Not NAMPT, Provides Additional Support for NAD Synthesis in Esophageal Precancerous Lesions. Nutrients, 2022, Nov-20, Volume: 14, Issue:22 Topics: Case-Control Studies; Esophageal Neoplasms; Humans; NAD; Niacin; Niacinamide; Nicotinamide Phosphori	2022
NAPRT, but Not NAMPT, Provides Additional Support for NAD Synthesis in Esophageal Precancerous Lesions. Nutrients, 2022, Nov-20, Volume: 14, Issue:22 Topics: Case-Control Studies; Esophageal Neoplasms; Humans; NAD; Niacin; Niacinamide; Nicotinamide Phosphori	2022
NAPRT, but Not NAMPT, Provides Additional Support for NAD Synthesis in Esophageal Precancerous Lesions. Nutrients, 2022, Nov-20, Volume: 14, Issue:22 Topics: Case-Control Studies; Esophageal Neoplasms; Humans; NAD; Niacin; Niacinamide; Nicotinamide Phosphori	2022
NAPRT, but Not NAMPT, Provides Additional Support for NAD Synthesis in Esophageal Precancerous Lesions. Nutrients, 2022, Nov-20, Volume: 14, Issue:22 Topics: Case-Control Studies; Esophageal Neoplasms; Humans; NAD; Niacin; Niacinamide; Nicotinamide Phosphori	2022
NAPRT, but Not NAMPT, Provides Additional Support for NAD Synthesis in Esophageal Precancerous Lesions. Nutrients, 2022, Nov-20, Volume: 14, Issue:22 Topics: Case-Control Studies; Esophageal Neoplasms; Humans; NAD; Niacin; Niacinamide; Nicotinamide Phosphori	2022
NAPRT, but Not NAMPT, Provides Additional Support for NAD Synthesis in Esophageal Precancerous Lesions. Nutrients, 2022, Nov-20, Volume: 14, Issue:22 Topics: Case-Control Studies; Esophageal Neoplasms; Humans; NAD; Niacin; Niacinamide; Nicotinamide Phosphori	2022
Combination of sorafenib and angiotensin-II receptor blocker attenuates preneoplastic lesion development in a non-diabetic rat model of steatohepatitis. Journal of gastroenterology, 2014, Volume: 49, Issue:10 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anticarcinogenic Agents; Antineoplastic Combined C	2014
[Special forms of sideroachrestic anemia]. Zeitschrift fur arztliche Fortbildung, 1970, Oct-15, Volume: 64, Issue:20 Topics: Adult; Anemia, Macrocytic; Erythropoiesis; Gastroenteritis; Humans; Karyometry; Leukoplakia; Male; M	1970
[Letter: Therapy and prognosis of lichen ruber mucosae oris]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1973, Volume: 24, Issue:8 Topics: Aged; Betamethasone; Female; Humans; Lichen Planus; Male; Niacinamide; Oral Manifestations; Precance	1973
[Pyridine nucleotide metabolism in rat liver during carcinogenesis]. Zeitschrift fur Krebsforschung, 1966, Volume: 68, Issue:2 Topics: Animals; Dactinomycin; Hepatectomy; Liver; Liver Neoplasms; Liver Regeneration; Morpholines; NAD; NA	1966

Article

Year

NAPRT, but Not NAMPT, Provides Additional Support for NAD Synthesis in Esophageal Precancerous Lesions.